✦ LIBER ✦

P-223 Decline in circulating cyfra predicts objective response and survival in advanced non small cell lung cancer (nsclc) patients (pts) subjected to chemotherapy (ct)

✍ Scribed by Cafferata, Mara Argenide; Ardizzoni, Andrea; Paganuzzi, Michela; Marroni, Paola; Filiberti, Rosangela; Puntoni, Riccardo; Rosso, Riccardo

Book ID: 118571924
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92192-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PD-072 Circulating nucleosomes and cyfra

PD-072 Circulating nucleosomes and cyfra 21-1 predict early theresponse to chemotherapy in patients with advanced non-small cell lung cancer

✍ Holdenrieder, S.; Stieber, P.; von Pawel, J.; Raith, H.; Nagel, D.; Feldmann, K. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 288 KB

The predictive value of neuroendocrine m

The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer

✍ Gajra, Ajeet; Tatum, Arthur H; Newman, Nancy; Gamble, Gary P; Lichtenstein, Sonj 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 203 KB

P-546 Thiol-disulfide ratio (TDR) in blo

P-546 Thiol-disulfide ratio (TDR) in blood as a predictive in vitro test for treatment effect evaluation and individual chemotherapy (CT) choice in patients with advanced non-small cell lung cancer (NSCLC)

✍ Obodnikov, Oleksandr O.; Parshikov, Oleksandr; Orlovskiy, Oleksiy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P-254 FDG-PET response predicts overall

P-254 FDG-PET response predicts overall and disease free survival after induction chemotherapy with docetaxel (D) plus carboplatin (C) and erythropoietin (EPO) in locally advanced (stage III) non-small cell lung cancer (NSCLC)

✍ Griesinger, Frank; Glätzner, Tim; Schmidberger, Heinz; Andreas, Stefan; Schirren 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB